ARTICLE | Company News
Norak, AstraZeneca deal
November 8, 2004 8:00 AM UTC
Under a second license agreement, AZN will use Norak's Transfluor fluorescence-based GPCR technology to advance lead compounds discovered under the companies' 2002 high throughput screening deal. ...